Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 19:10:12.
doi: 10.1186/1471-2334-10-12.

Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants

Affiliations

Effect of heptavalent pneumococcal conjugate vaccination on invasive pneumococcal disease in preterm born infants

Simon Rückinger et al. BMC Infect Dis. .

Abstract

Background: Evidence for protection of preterm born infants from invasive pneumococcal disease (IPD) by 7-valent pneumococcal conjugate vaccination (PCV7) is relatively sparse. Data from randomized trials is based on relatively small numbers of preterm born children.

Methods: We report data from active prospective surveillance of IPD in children in Germany. The cohorts of preterm born children in 2000 and 2007 and the respective whole birth cohorts are compared regarding occurrence of IPD.

Results: After introduction of PCV7 we observed a reduction in the rate of IPD in preterm born infants comparing the 2000 and 2007 birth cohort. The rate of IPD among the whole birth cohorts was reduced from 15.0 to 8.5 notifications per 100,000 (P < .001). The impact among the preterm birth cohort was comparable: A reduction in notification rate from 26.1 to 16.7 per 100,000 comparing the 2000 with the 2007 preterm birth cohort (P = .39). Preterm born infants with IPD were either unvaccinated or vaccinated delayed or incomplete.

Conclusions: This adds to evidence that PCV7 also protects preterm born infants effectively from IPD. Preterm born infants should receive pneumococcal vaccination according to their chronological age.

PubMed Disclaimer

Similar articles

Cited by

References

    1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet. 2009;374:893–902. doi: 10.1016/S0140-6736(09)61204-6. - DOI - PubMed
    1. de Bedford H, Louvois J, Halket S, Peckham C, Hurley R, Harvey D. Meningitis in infancy in England and Wales: follow up at age 5 years. Bmj. 2001;323:533–536. doi: 10.1136/bmj.323.7312.533. - DOI - PMC - PubMed
    1. Davidson M, Schraer CD, Parkinson AJ, Campbell JF, Facklam RR, Wainwright RB, Lanier AP, Heyward WL. Invasive pneumococcal disease in an Alaska native population, 1980 through 1986. Jama. 1989;261:715–718. doi: 10.1001/jama.261.5.715. - DOI - PubMed
    1. Haddy RI, Perry K, Chacko CE, Helton WB, Bowling MG, Looney SW, Buck GE. Comparison of incidence of invasive Streptococcus pneumoniae disease among children before and after introduction of conjugated pneumococcal vaccine. Pediatr Infect Dis J. 2005;24:320–323. doi: 10.1097/01.inf.0000157090.40719.9b. - DOI - PubMed
    1. Rendi-Wagner P, Georgopoulos A, Kundi M, Mutz I, Mattauch M, Nowak J, Mikolasek A, Vecsei A, Kollaritsch H. Prospective surveillance of incidence, serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae among hospitalized children in Austria. J Antimicrob Chemother. 2004;53:826–831. doi: 10.1093/jac/dkh211. - DOI - PubMed

Publication types

MeSH terms

Substances